FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

10843002: Anterior pituitary hormone (substance)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
18833017 Anterior pituitary hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
600665019 Anterior pituitary hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
18833017 Anterior pituitary hormone en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
18833017 Anterior pituitary hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
600665019 Anterior pituitary hormone (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
600665019 Anterior pituitary hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

40 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Anterior pituitary hormone Is a Pituitary hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Anterior pituitary hormone Is a Hypothalamic and pituitary hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Anterior pituitary hormone Is a Pituitary hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Anterior pituitary hormone Is a Pituitary hormone true Inferred relationship Existential restriction modifier (core metadata concept)
Anterior pituitary hormone Has disposition Anterior pituitary hormone true Inferred relationship Existential restriction modifier (core metadata concept)
Anterior pituitary hormone Is a hormones et leurs métabolites et précurseurs false Inferred relationship Existential restriction modifier (core metadata concept)
Anterior pituitary hormone Is a Substance categorized by disposition false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Pituitary gonadotropin Is a True Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Adrenocorticotropic hormone Is a False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Thyrotrophin (substance) Is a True Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Human growth hormone Is a False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Poisoning caused by combination analgesic of undetermined intent Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Accidental corticotrophin poisoning (disorder) Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Intentional corticotrophin poisoning Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Corticotrophin poisoning of undetermined intent Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Accidental gonadotrophin poisoning Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Intentional gonadotrophin poisoning Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Gonadotrophin poisoning of undetermined intent Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Accidental somatotrophin poisoning Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Intentional somatotrophin poisoning Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatotrophin poisoning of undetermined intent Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Poisoning caused by somatotropin Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Poisoning caused by corticotropin (disorder) Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Poisoning caused by anterior pituitary hormone (disorder) Causative agent (attribute) True Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept) 1
Poisoning caused by oxytocic agent Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Poisoning by gonadotropin Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Intentional combined analgesic overdose Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Anterior pituitary hormone poisoning NOS Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Oxytocic agent poisoning NOS Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Corticotropin preparation (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing melatonin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Corticotrophins The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 1,8 UI (0,6 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 1,2 UI (0,4 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 0,6 UI (0,2 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (rmc) 24 UI (8 mg), fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 16 UI (5,33 mg), poudre et diluant pour injection avec nécessaire de reconstitution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 12 UI (4 mg), fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 2,4 UI (0,8 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 3 UI (1 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 16 UI (5,33 mg), fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (rmc) 10 UI (3,33 mg), fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (rmc) 4 UI (1,33 mg), fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 4 UI (1,33 mg), fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 36 UI (12 mg), cartouche de poudre pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 18 UI (6 mg), cartouche de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 36 UI (12 mg), cartouche de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 72 UI (24 mg), cartouche de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 3,6 UI (1,2 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 4,2 UI (1,4 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 4,8 UI (1,6 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 5,4 UI (1,8 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (efficacité biologique relative) 6 UI (2 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (epr) 3,33 mg/mL, cartouche de 1,5 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (epr) 6,66 mg/mL, cartouche de 1,5 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
somatropine (epr) 10 mg/mL, cartouche de 1,5 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatrophic hormone (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Human growth hormone recombinant preparation (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing somatotropin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Anterior pituitary extract preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing corticotropin releasing factor (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing somatropin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin [2] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 10mg/vial solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 10mg/2mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.6mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.2mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 2mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 0.8mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 2.0mg/.25mL powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 13.8mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.5mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.4mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 0.2mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 5.8mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.4mg/.25mL powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.6mg/.25mL powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.2mg/.25mL powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 0.8mg/unt powder (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 0.6mg/unt powder (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.8mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 0.44mg/unit powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.8mg/.25mL powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.0mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 0.4mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Anterior pituitary hormone-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept) 1
Somatropin 12mg/vial powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 0.6mg/vial powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 15mg/1.5mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 5.0mg/1.5mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 5mg/vial powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 10mg/vial powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 6mg/vial powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 10.0mg/1.5mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 4mg/vial powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 8.8mg/vial powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 13.5mg/3mL injection solution 3mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 18mg/3mL injection solution 3mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 22.5mg/3mL injection solution 3mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin(rbe) 5mg(15iu)/mL injection solution 2mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Bovine growth hormone recombinant preparation (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Sometribove preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Corticotropin 80units/mL in gelatin injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Bovine growth hormone Is a True Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin (substance) Is a True Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Accidental gonadotrophin poisoning Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Intentional gonadotrophin poisoning Causative agent (attribute) False Anterior pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)

Page 1 of 2 End

This concept is not in any reference sets

Back to Start